Increasing Antibiotic Resistance in Shigella spp. from Infected New York City Residents, New York, USA
- PMID: 28098543
- PMCID: PMC5324786
- DOI: 10.3201/eid2302.161203
Increasing Antibiotic Resistance in Shigella spp. from Infected New York City Residents, New York, USA
Abstract
Approximately 20% of Shigella isolates tested in New York City, New York, USA, during 2013-2015 displayed decreased azithromycin susceptibility. Case-patients were older and more frequently male and HIV infected than those with azithromycin-susceptible Shigella infection; 90% identified as men who have sex with men. Clinical interpretation guidelines for azithromycin resistance and outcome studies are needed.
Keywords: Antimicrobial susceptibility; MSM; Shigella; azithromycin.
References
-
- Goldberg M. Shigella infection: epidemiology, microbiology, and pathogenesis. UpToDate. Alphen aan den Rijn (the Netherlands): Wolters Kluwer; 2016. [cited 2016 Sep 9]. http://www.uptodate.com/home
-
- American Academy of Pediatrics. Red book: 2012 report of the Committee on Infectious Diseases. 29th ed. Elk Grove (IL): American Academy of Pediatrics; 2012.
-
- Agha RGM. Shigella infection: treatment and prevention in adults. UpToDate. Alphen aan den Rijn (the Netherlands): Wolters Kluwer; 2015. [cited 2016 Sep 9]. http://www.uptodate.com/home
-
- Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 26th ed. CLSI supplement M100S. Wayne (PA): The Institute; 2016. p. 62.
-
- Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 24th informational supplement. Report no. eM100. Wayne (PA): The Institute; 2014.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous